Abortion Surveillance — United States, 2019
Katherine Kortsmit(National Center for Chronic Disease Prevention and Health Promotion), Maura K. Whiteman(National Center for Chronic Disease Prevention and Health Promotion), Michele G. Mandel(National Center for Chronic Disease Prevention and Health Promotion), Elizabeth Clark(National Center for Chronic Disease Prevention and Health Promotion), H. Pamela Pagano(National Center for Chronic Disease Prevention and Health Promotion), Jennifer A. Reeves(National Center for Chronic Disease Prevention and Health Promotion), Antoinette T. Nguyen(University of Alberta), Emily E. Petersen
Cited by 141
Related Papers
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
|MMWR Recommendations and Reports|2016|1.5k
Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016
|MMWR Morbidity and Mortality Weekly Report|2017|296
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Using a Patient Navigator to Improve Postpartum Care in an Urban Women's Health Clinic
|Obstetrics and Gynecology|2017|137
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|120